Analyst Ratings for Galmed Pharmaceuticals (GLMD)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 4.5 / 10
Percentile Rank: 46%
Rating Score: 4.5 / 10
Percentile Rank: 46%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/4/2025 | Maxim Group | Jason McCarthy | Downgrade | Hold (Buy) |
N/A (N/A) |
1.46 (0.66) |
-54.79% | Details |
| 8/8/2022 | Canaccord | Edward Nash | Downgrade | Hold (Buy) |
1.00 (5.00) |
0.44 (0.66) |
50% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
